Increased production of inflammatory cytokines by circulating monocytes in mesial temporal lobe epilepsy: A possible role in drug resistance

被引:5
作者
Milano, C. [1 ]
Montali, M. [2 ]
Barachini, S. [2 ]
Burzi, I. S. [2 ]
Pratesi, F. [3 ]
Petrozzi, L. [1 ]
Chico, L. [1 ]
Morganti, R. [4 ]
Gambino, G. [2 ]
Rossi, L. [2 ]
Ceravolo, R. [1 ]
Siciliano, G. [1 ]
Migliorini, P. [5 ]
Petrini, I. [3 ]
Pizzanelli, C. [1 ]
机构
[1] Univ Pisa, Dept Clin & Expt Med, Neurol Unit, Pisa, Italy
[2] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy
[3] Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy
[4] Univ Pisa, Sect Stat, Pisa, Italy
[5] Univ Pisa, Dept Clin & Expt Med, Clin Immunol & Allergy Unit, Pisa, Italy
关键词
Drug-resistant epilepsy; Mesial temporal lobe epilepsy; Neuroinflammation; Oxidative stress; Peripheral blood mononuclear cells; Cytokines; OXIDATIVE STRESS MARKERS; CHEMOATTRACTANT PROTEIN-1; STATUS EPILEPTICUS; ADAPTIVE IMMUNITY; RAT MODEL; IL-1-BETA; CHILDREN; SEIZURES; ILAE; EPILEPTOGENESIS;
D O I
10.1016/j.jneuroim.2023.578272
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We analyzed peripheral blood mononuclear cells (PBMCs) and serum inflammatory biomarkers in patients with mesial temporal lobe epilepsy (drug-resistant - DR, vs. drug-sensitive - DS). Patients with epilepsy showed higher levels of serum CCL2, CCL3, IL-8 and AOPP, and lower levels of FRAP and thiols compared to healthy controls (HC). Although none of the serum biomarkers distinguished DR from DS patients, when analysing intracellular cytokines after in vitro stimulation, DR patients presented higher percentages of IL-1 beta and IL-6 positive monocytes compared to DS patients and HC. Circulating innate immune cells might be implicated in DR epilepsy and constitute potential new targets for treatments.
引用
收藏
页数:11
相关论文
共 50 条
[21]   Systemic lupus erythematosus manifested as drug-resistant mesial temporal lobe epilepsy [J].
Polychronopoulos, P. ;
Giannopoulos, G. ;
Litsardopoulos, P. ;
Soldatos, P. ;
Chroni, E. .
NEUROLOGICAL SCIENCES, 2017, 38 (01) :197-200
[22]   Systemic lupus erythematosus manifested as drug-resistant mesial temporal lobe epilepsy [J].
P. Polychronopoulos ;
G. Giannopoulos ;
P. Litsardopoulos ;
P. Soldatos ;
E. Chroni .
Neurological Sciences, 2017, 38 :197-200
[23]   Increased Oxidative Stress Toxicity and Lowered Antioxidant Defenses in Temporal Lobe Epilepsy and Mesial Temporal Sclerosis: Associations with Psychiatric Comorbidities [J].
Maes, Michael ;
Supasitthumrong, Thitiporn ;
Limotai, Chusak ;
Michelin, Ana Paula ;
Matsumoto, Andressa Keiko ;
Semao, Laura de Oliveira ;
de Lima Pedrao, Joao Victor ;
Moreira, Estefania Gastaldello ;
Carvalho, Andre F. ;
Sirivichayakul, Sunee ;
Barbosa, Decio Sabbatini ;
Kanchanatawan, Buranee .
MOLECULAR NEUROBIOLOGY, 2020, 57 (08) :3334-3348
[24]   Resection of the epileptogenic lesion abolishes seizures and reduces inflammatory cytokines of patients with temporal lobe epilepsy [J].
Quirico-Santos, Thereza ;
Meira, Isabella D'Andrea ;
Gomes, Aline C. ;
Pereira, Valeria C. ;
Pinto, Moises ;
Monteiro, Marisa ;
Souza, Jorge M. ;
Alves-Leon, Soniza V. .
JOURNAL OF NEUROIMMUNOLOGY, 2013, 254 (1-2) :125-130
[25]   Multidimensional Approach Assessing the Role of Interleukin 1 Beta in Mesial Temporal Lobe Epilepsy [J].
Santos, Renato O. ;
Secolin, Rodrigo ;
Barbalho, Patricia G. ;
Silva-Alves, Mariana S. ;
Alvim, Marina K. M. ;
Yasuda, Clarissa L. ;
Rogerio, Fabio ;
Velasco, Tonicarlo R. ;
Sakamoto, Americo C. ;
Teixeira, Antonio L. ;
Cendes, Fernando ;
Maurer-Morelli, Claudia, V ;
Lopes-Cendes, Iscia .
FRONTIERS IN NEUROLOGY, 2021, 12
[26]   The role of ubiquitin/Nedd4-2 in the pathogenesis of mesial temporal lobe epilepsy [J].
Wu, Liwen ;
Peng, Jing ;
Kong, Huimin ;
Yang, Ping ;
He, Fang ;
Deng, Xiaolu ;
Gan, Na ;
Yin, Fei .
PHYSIOLOGY & BEHAVIOR, 2015, 143 :104-112
[27]   Somatic variants as a cause of drug-resistant epilepsy including mesial temporal lobe epilepsy with hippocampal sclerosis [J].
Carton, Robert J. ;
Doyle, Michael G. ;
Kearney, Hugh ;
Steward, Charles A. ;
Lench, Nicholas J. ;
Rogers, Anthony ;
Heinzen, Erin L. ;
McDonald, Seamus ;
Fay, Joanna ;
Lacey, Austin ;
Beausang, Alan ;
Cryan, Jane ;
Brett, Francesca ;
El-Naggar, Hany ;
Widdess-Walsh, Peter ;
Costello, Daniel ;
Kilbride, Ronan ;
Doherty, Colin P. ;
Sweeney, Kieron J. ;
O'Brien, Donncha F. ;
Henshall, David C. ;
Delanty, Norman ;
Cavalleri, Gianpiero L. ;
Benson, Katherine A. .
EPILEPSIA, 2024, 65 (05) :1451-1461
[28]   Brain but not serum BDNF levels are associated with structural alterations in the hippocampal regions in patients with drug-resistant mesial temporal lobe epilepsy [J].
Filimonova, Elena A. ;
Pashkov, Anton A. ;
Moysak, Galina I. ;
Tropynina, Anastasia Y. ;
Zhanaeva, Svetlana Y. ;
Shvaikovskaya, Anna A. ;
Akopyan, Anna A. ;
Danilenko, Konstantin V. ;
Aftanas, Lyubomir I. ;
Tikhonova, Maria A. ;
Rzaev, Jamil A. .
FRONTIERS IN NEUROSCIENCE, 2023, 17
[29]   Validation of diagnostic tests for depressive disorder in drug-resistant mesial temporal lobe epilepsy [J].
Zingano, Bianca de Lemos ;
Guarnieri, Ricardo ;
Diaz, Alexandre Paim ;
Schwarzbold, Marcelo Liborio ;
Horta Bicalho, Maria Alice ;
Claudino, Lucia Sukys ;
Markowitsch, Hans J. ;
Wolf, Peter ;
Lin, Katia ;
Walz, Roger .
EPILEPSY & BEHAVIOR, 2015, 50 :61-66
[30]   Circadian rhythm of blood pressure in patients with drug-resistant mesial temporal lobe epilepsy [J].
Viloria-Alebesque, Alejandro ;
Bellosta-Diago, Elena ;
Navarro-Perez, Maria Pilar ;
Santos-Lasaosa, Sonia ;
Mauri-Llerda, Jose Angel .
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2023, 108 :43-48